Showing Results for
- Academic Journals (33)
Search Results
- 33
Academic Journals
- 33
- Search Terms:
- 1From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedBackground Primary systemic vasculitis presenting in childhood is an uncommon but serious condition. As these patients transfer to adult clinics for continuing care, defining long term outcomes with emphasis on...
- 2From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedObjective Juvenile Systemic Lupus Erythematosus (SLE) varies by location and ethnicity. This study describes the clinical, laboratory profile and outcome of juvenile SLE seen at Philippine General Hospital (PGH) from...
- 3From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedIdiopathic osteolysis or disappearing bone disease is a condition characterized by the spontaneous onset of rapid destruction and resorption of a single bone or multiple bones. Disappearing bone disorder is a disease of...
- 4From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedBackground The glucocorticoid receptor gene (NR3C1) has been suggested as a candidate gene affecting juvenile idiopathic arthritis (JIA) course and prognosis. The purpose of this study is to investigate the...
- 5From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedInflammatory myositis is reported in 4-16% of adult systemic lupus erythematosus (SLE) patients. The aim of this study was to determine the prevalence of myositis in a cohort of pediatric SLE patients in the...
- 6From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedAlthough musculoskeletal ultrasound (MSUS) has emerged as an indispensible tool among physicians involved in musculoskeletal medicine in the last two decades, only recently has it become more attractive to pediatric...
- 7From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedObjective Although electronic medical records (EMRs) have facilitated care for children with juvenile idiopathic arthritis (JIA), analyses of treatment outcomes have required paper based or manually re-entered data....
- 8From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedThe United States pediatric population with chronic health conditions is expanding. Currently, this demographic comprises 12-18% of the American child and youth population. Affected children often receive fragmented,...
- 9From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedSpinal epidural lipomatosis is a rare complication of chronic corticosteroid treatment. We report a new pediatric case and an analysis of this and 19 pediatric cases identified in the international literature. The...
- 10From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedThere is a debate whether post-streptococcal reactive arthritis (PSRA) is a separate entity or a condition on the spectrum of acute rheumatic fever (ARF). We believe that PSRA is a distinct entity and in this paper we...
- 11From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedBackground Children with complex medical issues experience barriers to the transition of care from pediatric to adult providers. We sought to identify these barriers by elucidating the experiences of patients with...
- 12From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedRaynaud's phenomenon (RP) is an extremely unusual finding in early infancy. In the present report we describe a one-month-old previously healthy male infant who presented with unilateral acrocyanosis. Although infantile...
- 13From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedAuthors: Randy Q Cron (corresponding author) [1]; Hendrik Schulze-Koops [2] From its inception in 1997, the ACR/EULAR exchange program (AEEP) has brought young rheumatologists together from Europe and the USA. Over...
- 14From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a...
- 15From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedFor children with rheumatic conditions, the available pediatric rheumatology workforce mitigates their access to care. While the subspecialty experiences steady growth, a critical workforce shortage constrains access....
- 16From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedBackground Several studies have noted the significance of measuring anti-cyclic citrullinated peptide (CCP) antibodies in juvenile idiopathic arthritis (JIA) as an important indicator for destructive disease, as is...
- 17From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedChildhood systemic vasculitides are a group of rare diseases with multi-organ involvement and potentially devastating consequences. After establishment of new classification criteria (Ankara consensus conference in...
- 18From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedBackground Chronic non-specific musculoskeletal pain (CNSMSP) may develop in childhood and adolescence, leading to disability and reduced quality of life that continues into adulthood. The purpose of the study was to...
- 19From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedHenoch-Schönlein purpura is one of the most common forms of systemic vasculitis of childhood. We report the response to anakinra, the interleukin-1 receptor antagonist, in a 9 year old girl without prior medical...
- 20From: Pediatric Rheumatology. (Vol. 9) Peer-ReviewedBackground Intravenous immunoglobulin (IVIg) treatment results in an effective response from patients with acute-phase Kawasaki disease (KD), but 16.5% of them remain nonresponsive to IVIg. To address this...